Cat. #151226
Anti-HLADQ3, DQ4 & DR4 [TAL 12.1]
Cat. #: 151226
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: Human Leukocyte Antigens DQ3 , DQ4 & DR4
Class: Monoclonal
Application: ELISA ; FACS ; WB
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Julia Bodmer
Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-HLADQ3, DQ4 & DR4 [TAL 12.1]
- Research fields: Immunology
- Clone: TAL 12.1
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Reactivity: Human
- Host: Mouse
- Application: ELISA ; FACS ; WB
- Description: TAL 12.1 may be used for HLA typing.
- Isotype: IgG2b
- Myeloma used: NS0
Target Details
- Target: Human Leukocyte Antigens DQ3 , DQ4 & DR4
- Target background: Human Leukocyte Antigens (HLA) are highly polymorphic proteins that are involved in the presentation of antigens to the T-cell receptor. There are two classes of HLA antigens, class I (HLA-A, HLA-B and HLA-C) and class II (HLA-D).
Applications
- Application: ELISA ; FACS ; WB
Handling
- Format: Liquid
- Concentration: 0.9-1.1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Shipping at 4° C
References
- Bodmer et al. 1989. Cold Spring Harb Symp Quant Biol. 54 Pt 1:471-6. PMID: 2484167.
- Monoclonal antibodies and the epitope distribution of HLA class II polymorphisms.
